Clinical Report: Neurological Adverse Events Linked to Atorvastatin
Overview
This study identifies multiple neurological adverse events associated with atorvastatin, based on a disproportionality analysis of the FAERS database.
Background
Atorvastatin is a commonly prescribed statin for managing hyperlipidemia and coronary artery disease. While it is known for its cardiovascular benefits, there is an association with neurological adverse events.
Data Highlights
Adverse Event
PRR
χ2
EBGM05
Myasthenia gravis
5.65
748.22
4.82
Axonal neuropathy
6.15
117.78
4.14
Peripheral sensory neuropathy
3.42
182.34
2.80
Encephalitis toxic
7.76
17.11
2.39
Brain fog
2.94
168.76
2.46
Acute necrotising myelitis
832.92
N/A
38.61
Vibration syndrome
37.02
N/A
14.51
Radiculitis brachial
26.03
N/A
13.57
Key Findings
32 neurological adverse event signals remained significant after excluding confounding factors.
Myasthenia gravis had a PRR of 5.65, indicating a strong association with atorvastatin.
Axonal neuropathy and peripheral sensory neuropathy also showed significant PRR values of 6.15 and 3.42, respectively.
Encephalitis toxic and brain fog were identified as notable central nervous system disorders linked to atorvastatin.
Acute necrotising myelitis exhibited an exceptionally high PRR of 832.92, indicating a rare but significant risk.
Clinical Implications
Clinicians should be aware of the neurological adverse events associated with atorvastatin.
